Home » Stocks » NH

NantHealth, Inc. (NH)

Stock Price: $2.21 USD -0.17 (-7.14%)
Updated May 13, 2021 1:54 PM EDT - Market open
Market Cap 271.00M
Revenue (ttm) 71.16M
Net Income (ttm) -94.80M
Shares Out 111.32M
EPS (ttm) -0.51
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a
Trading Day May 13
Last Price $2.21
Previous Close $2.38
Change ($) -0.17
Change (%) -7.14%
Day's Open 2.36
Day's Range 2.18 - 2.43
Day's Volume 146,664
52-Week Range 1.90 - 6.60

News

Hide News
  • All
  • Videos
  • Press Releases
  • Conversation

CULVER CITY, Calif.--(BUSINESS WIRE)--NantHealth, Inc. (NASDAQ-GS: NH), a provider of enterprise solutions that help businesses transform complex data into actionable insights, today reported financial ...

6 days ago - Business Wire

EL SEGUNDO, Calif.--(BUSINESS WIRE)--NantHealth, Inc. (NASDAQ: NH), a provider of enterprise solutions that help businesses transform complex data into actionable insights, today announced the launch of...

1 week ago - Business Wire

CULVER CITY, Calif.--(BUSINESS WIRE)--NantHealth, Inc. (NASDAQ-GS: NH), a provider of enterprise solutions that help businesses transform complex data into actionable insights, today announced that it w...

1 week ago - Business Wire

EL SEGUNDO, Calif.--(BUSINESS WIRE)--NantHealth, Inc. (NASDAQ: NH), today announced a new population health management product that pulls together disparate data to provide a full 360-degree picture of ...

1 month ago - Business Wire

CULVER CITY, Calif.--(BUSINESS WIRE)--NantHealth, Inc. (NASDAQ-GS: NH), a provider of enterprise solutions that help transform complex data into actionable insights, today reported financial results for...

2 months ago - Business Wire

3 Top Medical Info Systems Stocks to Beat COVID-19 Resurgence Crisis

Other stocks mentioned: CERN, DGX, MDRX, NXGN, OMCL
3 months ago - Zacks Investment Research

NEW YORK & EL SEGUNDO, Calif.--(BUSINESS WIRE)--NantHealth, Inc. (NASDAQ: NH), a provider of enterprise solutions that help businesses transform complex data into actionable insights, today announced a ...

3 months ago - Business Wire

Investors need to pay close attention to NantHealth (NH) stock based on the movements in the options market lately.

4 months ago - Zacks Investment Research

EL SEGUNDO, Calif. & SAN ANTONIO, Texas--(BUSINESS WIRE)--NantHealth, Inc. (NASDAQ: NH), a provider of enterprise solutions that help businesses transform complex data into actionable insights, today pr...

5 months ago - Business Wire

CULVER CITY, Calif. & EL SEGUNDO, Calif.--(BUSINESS WIRE)--NantHealth, Inc. (NASDAQ: NH), a provider of enterprise solutions that help businesses transform complex data into actionable insights, today a...

5 months ago - Business Wire

NantHealth, Inc. (NH) Q3 2020 Results - Earnings Call Transcript

6 months ago - Seeking Alpha

CULVER CITY, Calif.--(BUSINESS WIRE)--NantHealth, Inc. (NASDAQ: NH), a next-generation, evidence-based, personalized healthcare company, presented virtually with NantOmics and ImmunityBio on September 2...

7 months ago - Business Wire

CULVER CITY, Calif.--(BUSINESS WIRE)--NantHealth, Inc. (NASDAQ: NH), a next-generation, evidence-based, personalized healthcare company, today announced a series of secure Application Programming Interf...

7 months ago - Business Wire

CULVER CITY, Calif.--(BUSINESS WIRE)--NantHealth, Inc. (NASDAQ: NH), a next-generation, evidence-based, personalized healthcare company, announced the national rollout of NaviNet AllPayer, a subscriptio...

7 months ago - Business Wire

NantHealth, Inc. (NH) Q2 2020 Results - Earnings Call Transcript

9 months ago - Seeking Alpha

NantHealth, Inc. (NH) delivered earnings and revenue surprises of -16.67% and -3.38%, respectively, for the quarter ended June 2020.

9 months ago - Zacks Investment Research

CULVER CITY, Calif.--(BUSINESS WIRE)--NantHealth, Inc.

9 months ago - Business Wire

NantHealth Points To The Future Of Healthcare

10 months ago - Seeking Alpha

CULVER CITY, Calif.--(BUSINESS WIRE)--NantHealth, Inc. (NASDAQ: NH), a next-generation, evidence-based, personalized healthcare company, today announced the publication of a study in JCI Insight, a peer...

10 months ago - Business Wire

NantHealth (NH) saw a big move last session, as its shares jumped more than 9% on the day, amid huge volumes.

11 months ago - Zacks Investment Research

NantHealth, Inc. (NH) Management on Q1 2020 Results - Earnings Call Transcript

1 year ago - Seeking Alpha

NantHealth Inc (NH) delivered earnings and revenue surprises of 14.29% and -5.80%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?

1 year ago - Zacks Investment Research

These exciting stocks to buy for aggressive investors might be small, but they have massive growth potential when the pandemic clears up. The post 7 Top Stocks to Buy for Aggressive Investors appeared...

Other stocks mentioned: DRD, ENPH, IFMK, OESX, XBIT
1 year ago - InvestorPlace

NantHealth, Inc. (NH) CEO Dr.

1 year ago - Seeking Alpha

Shares of NantHealth Inc. soared 56% in premarket trading on Tuesday after the company said it had developed an artificial intelligence software used to improve lung-cancer diagnoses.

1 year ago - Market Watch

NantHealth Scores Milestone FDA Approval While SaaS Business Grows

1 year ago - Seeking Alpha

NantHealth, Inc. (NH) CEO Patrick Soon Shiong on Q3 2019 Results - Earnings Call Transcript

1 year ago - Seeking Alpha

NantHealth, Inc. (NH) delivered earnings and revenue surprises of -75.00% and -4.46%, respectively, for the quarter ended September 2019.

1 year ago - Zacks Investment Research

NantHealth, Inc. (NH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report.

1 year ago - Zacks Investment Research

NantHealth's (NH) CEO Patrick Soon-Shiong on Q2 2019 Results - Earnings Call Transcript

1 year ago - Seeking Alpha

NantHealth, Inc. (NH) delivered earnings and revenue surprises of 55.56% and 7.03%, respectively, for the quarter ended June 2019.

1 year ago - Zacks Investment Research

NantHealth, Inc. (NH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report.

1 year ago - Zacks Investment Research

NantHealth, Inc. (NH) CEO Patrick Soon-Shiong on Q1 2019 Results - Earnings Call Transcript

2 years ago - Seeking Alpha

NantHealth's (NH) CEO Patrick Soon-Shiong on Q4 2018 Results - Earnings Call Transcript

2 years ago - Seeking Alpha

About NH

NantHealth, Inc., together with its subsidiaries, operates as a healthcare IT company in the United States and internationally. It offers Eviti, a software-as-a-service (SaaS) based clinical decision support solution that centralizes clinical content and treatment cost data from Medicare reimbursements and treatment toxicity data; Eviti Connect, which utilizes the platform to offer pre-authorization automation that helps payers and providers navigate the complexities of cancer care; and Eviti Advisor product that allows physicians to access the... [Read more...]

Industry
Health Information Services
IPO Date
Jun 2, 2016
CEO
Patrick Soon-Shiong
Employees
352
Stock Exchange
NASDAQ
Ticker Symbol
NH
Full Company Profile

Financial Performance

In 2020, NantHealth's revenue was $73.17 million, a decrease of -5.50% compared to the previous year's $77.43 million. Losses were -$56.33 million, -10.25% less than in 2019.

Financial Statements

Analyst Forecasts

According to 2 analysts, the average rating for NantHealth stock is "Strong Buy." The 12-month stock price forecast is 3.75, which is an increase of 69.68% from the latest price.

Price Target
$3.75
(69.68% upside)
Analyst Consensus: Strong Buy